Name: | Verapamil |
---|---|
PubChem Compound ID: | 10072830 |
Description: | A calcium channel blocker that is a class IV anti-arrhythmia agent. |
Molecular formula: | C27H38N2O4 |
Molecular weight: | 457.62 g/mol |
Name: | Verapamil |
---|---|
Name (isomeric): | DB00661 |
Drug Type: | small molecule |
Description: | A calcium channel blocker that is a class IV anti-arrhythmia agent. |
Synonyms: |
Verapamil [Usan:Ban:Inn]; Verapamilum [INN-Latin]; Verapamil HCl; Verapamilo [INN-Spanish]
|
Brand: | Securon, Vasolan, Apo-Verap, Dignover, Cordilox, Cardibeltin, Drosteakard, Cardiagutt, Calan SR, Isoptin SR, Calan, NU-Verap, Novo-Veramil, Verelan, Univer, Arpamyl, Verelan PM, Verexamil, Isoptimo, Quasar, Dilacoran, Isoptin, Veraptin, Veramex, Geangin, Iproveratril, Veracim, Covera-HS, Berkatens |
Brand name mixture: | Tarka(trandolapril + verapamil hydrochloride) |
Category: | Vasodilator Agents, Antiarrhythmic Agents, Calcium Channel Blockers, Anti-Arrhythmia Agents |
CAS number: | 52-53-9 |
Indication: | For the treatment of hypertension, angina, and cluster headache prophylaxis. |
---|---|
Pharmacology: | Verapamil is an L-type calcium channel blocker that also has antiarrythmic activity. The R-enantiomer is more effective at reducing blood pressure compared to the S-enantiomer. However, the S-enantiomer is 20 times more potent than the R-enantiomer at prolonging the PR interval in treating arrhythmias. |
Mechanism of Action: |
Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel su...
show more »
Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known.
show less « |
Absorption: | 90% |
Protein binding: | 90% |
Route of elimination: | Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days. About 3% to 4% is excreted in the urine as unchanged drug. |
Half Life: | 2.8-7.4 hours |
Toxicity: | LD50=8 mg/kg (i.v. in mice) |
Affected organisms: | Humans and other mammals |
Food interaction: |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug interaction: |
|
UniProt ID: | Q13936 | ||||
---|---|---|---|---|---|
Gene: | CACNA1C | ||||
Actions: | inhibitor | ||||
References: |
|
UniProt ID: | Q01668 | |
---|---|---|
Gene: | CACNA1D | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | O60840 | |
---|---|---|
Gene: | CACNA1F | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q13698 | |
---|---|---|
Gene: | CACNA1S | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q02641 | |
---|---|---|
Gene: | CACNB1 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q08289 | |
---|---|---|
Gene: | CACNB2 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | P54284 | |
---|---|---|
Gene: | CACNB3 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | O00305 | |
---|---|---|
Gene: | CACNB4 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q9P0X4 | ||
---|---|---|---|
Gene: | CACNA1I | ||
Actions: | inhibitor | ||
References: |
|
UniProt ID: | O43497 | |||
---|---|---|---|---|
Gene: | CACNA1G | |||
Actions: | inhibitor | |||
References: |
|
UniProt ID: | Q00975 | |
---|---|---|
Gene: | CACNA1B | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | O00555 | |
---|---|---|
Gene: | CACNA1A | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q12809 | ||||||
---|---|---|---|---|---|---|---|
Gene: | KCNH2 | ||||||
Actions: | inhibitor | ||||||
References: |
|
UniProt ID: | Q14524 | |
---|---|---|
Gene: | SCN5A | |
Actions: | other | |
References: |
|
UniProt ID: | Q14654 | |||
---|---|---|---|---|
Gene: | KCNJ11 | |||
Actions: | inhibitor | |||
References: |
|
UniProt ID: | P31645 | ||
---|---|---|---|
Gene: | SLC6A4 | ||
Actions: | other/unknown | ||
References: |
|
UniProt ID: | P08684 | ||||
---|---|---|---|---|---|
Gene: | CYP3A4 | ||||
Actions: | substrate, inhibitor | ||||
References: |
|
UniProt ID: | P20815 | |||
---|---|---|---|---|
Gene: | CYP3A5 | |||
Actions: | substrate, inhibitor | |||
References: |
|
UniProt ID: | P24462 | ||
---|---|---|---|
Gene: | CYP3A7 | ||
Actions: | substrate, inhibitor | ||
References: |
|
UniProt ID: | P05177 | ||
---|---|---|---|
Gene: | CYP1A2 | ||
Actions: | substrate | ||
References: |
|
UniProt ID: | P11712 | ||
---|---|---|---|
Gene: | CYP2C9 | ||
Actions: | substrate, inhibitor | ||
References: |
|
UniProt ID: | P10632 | ||
---|---|---|---|
Gene: | CYP2C8 | ||
Actions: | substrate | ||
References: |
|
UniProt ID: | P33261 | |
---|---|---|
Gene: | CYP2C19 | |
Actions: | substrate | |
References: |
|
UniProt ID: | P33260 | |
---|---|---|
Gene: | CYP2C18 | |
Actions: | substrate | |
References: |
|
UniProt ID: | P20813 | |
---|---|---|
Gene: | CYP2B6 | |
Actions: | substrate, inducer | |
References: |
|
UniProt ID: | P10635 | |
---|---|---|
Gene: | CYP2D6 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | P08183 | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene: | ABCB1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Actions: | substrate, inhibitor, inducer | ||||||||||||||||||||||||||||||||||||||||||||||||||
References: |
|
UniProt ID: | O15245 | ||
---|---|---|---|
Gene: | SLC22A1 | ||
Actions: | inhibitor | ||
References: |
|
UniProt ID: | O15438 | |
---|---|---|
Gene: | ABCC3 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | O15439 | ||
---|---|---|---|
Gene: | ABCC4 | ||
Actions: | inhibitor | ||
References: |
|
UniProt ID: | O76082 | ||
---|---|---|---|
Gene: | SLC22A5 | ||
Actions: | inhibitor | ||
References: |
|
UniProt ID: | O95342 | |
---|---|---|
Gene: | ABCB11 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | P33527 | |
---|---|---|
Gene: | ABCC1 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | P46721 | ||
---|---|---|---|
Gene: | SLCO1A2 | ||
Actions: | inhibitor | ||
References: |
|
UniProt ID: | Q5T3U5 | |
---|---|---|
Gene: | ABCC10 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q92887 | |
---|---|---|
Gene: | ABCC2 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q9H015 | ||
---|---|---|---|
Gene: | SLC22A4 | ||
Actions: | inhibitor | ||
References: |
|
UniProt ID: | Q9UNQ0 | |
---|---|---|
Gene: | ABCG2 | |
Actions: | inhibitor | |
References: |
|
UniProt ID: | Q9Y6L6 | |
---|---|---|
Gene: | SLCO1B1 | |
Actions: | inhibitor | |
References: |
|